Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas. | Cancers (Basel) | 2023 | 38201593 | PubTator, text mining | PubMed |
| Progress in Glioma Stem Cell Research. | Cancers (Basel) | 2023 | 38201528 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia: State of the Art and Recent Advances. | Cancers (Basel) | 2023 | 38201469 | PubTator, text mining | PubMed |
| Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma. | Cells | 2023 | 38201238 | PubTator, text mining | PubMed |
| Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma. | Cells | 2023 | 38201229 | PubTator, text mining | PubMed |
| New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network. | Transl Cancer Res | 2023 | 38197076 | PubTator, text mining | PubMed |
| Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. | Front Immunol | 2023 | 38179040 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in urinary tumors: clinical application, challenge, and perspectives. | Front Oncol | 2023 | 38173833 | PubTator, text mining | PubMed |
| Potential impact of cuproptosis-related genes on tumor immunity in esophageal carcinoma. | Aging (Albany NY) | 2023 | 38159255 | PubTator, text mining | PubMed |
| Comprehensively prognostic and immunological analysis of VRK Serine/Threonine Kinase 1 in pan-cancer and identification in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 38157278 | PubTator, text mining | PubMed |
| Human IgM-expressing memory B cells. | Front Immunol | 2023 | 38143767 | PubTator, text mining | PubMed |
| Deciphering Potential Role of Hippo Signaling Pathway in Breast Cancer: A Comprehensive Review. | Curr Pharm Des | 2023 | 38141194 | PubTator, text mining | PubMed |
| Advances in Diagnostic Tools and Therapeutic Approaches for Gliomas: A Comprehensive Review. | Sensors (Basel) | 2023 | 38139688 | PubTator, text mining | PubMed |
| Exosomes from Von Hippel-Lindau-Null Cancer Cells Promote Metastasis in Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 38139136 | PubTator, text mining | PubMed |
| Opportunities in Cancer Therapies: Deciphering the Role of Cancer Stem Cells in Tumour Repopulation. | Int J Mol Sci | 2023 | 38139085 | PubTator, text mining | PubMed |
| Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells. | Biomedicines | 2023 | 38137469 | PubTator, text mining | PubMed |
| Unlocking Dendritic Cell-Based Vaccine Efficacy through Genetic Modulation-How Soon Is Now? | Genes (Basel) | 2023 | 38136940 | PubTator, text mining | PubMed |
| Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies. | Cancers (Basel) | 2023 | 38136311 | PubTator, text mining | PubMed |
| Immune Escape in Glioblastoma: Mechanisms of Action and Implications for Immune Checkpoint Inhibitors and CAR T-Cell Therapy. | Biology (Basel) | 2023 | 38132354 | PubTator, text mining | PubMed |
| Exploring the prognostic value of S100A11 and its association with immune infiltration in breast cancer. | Sci Rep | 2023 | 38129538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=19